Navigation Links
Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans
Date:7/10/2008

soldiers -- and all that we can help heal with our support.

Purple Dog Tag has partnered with Veterans for America to serve as the project's initial beneficiary. An advocacy and humanitarian organization, Veterans for America's primary mission is to ensure that our country meets the needs of service members and veterans who have served in Operation Enduring Freedom and Operation Iraqi Freedom. Founded by Vietnam veteran turned activist Bobby Muller in 1980 as Vietnam Veterans of America, the organization has morphed over time, becoming Veterans for America in 2006. Other charitable organizations will be added over time.

"Ron Lawner's Catalyst and Veterans for America share a similar mission of supporting the underserved in our country. Purple Dog Tag's goal -- to provide financial support to programs that assist wounded service members, veterans and families as they readjust into society and their lives -- offers direct synergy to what we strive to achieve for our service members, veterans and families on a daily basis," said Bobby Muller, Founder of Veterans for America. "When Ron approached me to partner on the Purple Dog Tag initiative, there was no other answer but 'yes.'"

Sold online at purpledogtag.com, the tags are available in four styles: a long neck chain, a key chain, a lapel pin or croc tag. Price ranges from $5.00 to $10.00, with proceeds to support Veterans for America programs.

Purple Dog Tag is the first project from Ron Lawner's Catalyst, a company whose sole focus is to take on projects that bring awareness and education to the most underserved and at-risk groups in our country. Founded by Ron Lawner, former Chairman and Chief Creative Officer of advertising agency Arnold Worldwide, the company strives to empower philanthropic causes with marketing and advertising expertise in order to draw more mainstream attention and change the way Americans think about their role as it pertains to philanthropy.


'/>"/>
SOURCE Purpledogtag.com
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Purple: The Hottest Color for Fall in Shoes, Handbags and Martinis
2. Mom and Purple Bus Kick-off VoteHealthcare.org Bandwagon Tour
3. Study provides hope that some transplant patients could live free of antirejection drugs
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
5. USAID Provides Additional Wildfire Assistance to Greece
6. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
7. New knock-out gene model provides molecular clues to breast cancer
8. PreMD Provides Update on 510(k) Application for PREVU(x) POC
9. SIV infection of natural hosts provides new insights into HIV disease complexity
10. Microarray provides 3 genomic guides to breast cancer treatment decisions
11. Access Innovations Provides Support Services for Agis Network
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Breakfast BREAKS(R) 'Jump with Jill' Rockin' Nutrition Show Kicks off Tour in Florida Schools 2Health News:AUL Action Challenges Planned Parenthood to Reveal Financial Interest in Health Care Legislation 2Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 2Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 3Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 4Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 1Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 3TV Ads Trigger Mindless Eating 50512 1TV Ads Trigger Mindless Eating 50512 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 1Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 3